Tumor Lysis Syndrome is particularly relevant in the context of certain types of cancers such as acute leukemias, high-grade lymphomas (e.g., Burkitt lymphoma), and other rapidly growing tumors. It's a critical concern because it can occur spontaneously or more commonly after initiating cancer treatment such as chemotherapy, radiation, or targeted therapies.
